ASP Isotopes (NASDAQ:ASPI) Trading Up 8.4% - Should You Buy?

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report)'s share price was up 8.4% on Thursday . The company traded as high as $7.59 and last traded at $7.6870. Approximately 1,708,891 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 5,853,471 shares. The stock had previously closed at $7.09.Analyst Ratings ChangesASPI has been the topic of a number of recent research reports. Cantor Fitzgerald initiated coverage on ASP Isotopes in a research report on Thursday, December 4th. They issued an "overweight" rating and a $13.00 price objective on the stock. Loop Capital set a $15.00 target price on shares of ASP Isotopes in a research report on Monday, October 27th. Canaccord Genuity Group reiterated a "buy" rating and set a $11.00 price target on shares of ASP Isotopes in a research report on Monday, November 24th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of ASP Isotopes in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, ASP Isotopes currently has a consensus rating of "Hold" and an average price target of $13.00.View Our Latest Research Report on ASP IsotopesASP Isotopes Stock Up 7.0%The firm's 50 day simple moving average is $6.53 and its 200-day simple moving average is $8.40. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04. The stock has a market capitalization of $840.72 million, a price-to-earnings ratio of -5.84 and a beta of 3.47. ASP Isotopes (NASDAQ:ASPI - Get Free Report) last issued its earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.05). The firm had revenue of $4.89 million for the quarter, compared to analyst estimates of $2.25 million. ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%. Equities analysts expect that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year. Insider Buying and SellingIn other news, Chairman Paul Elliot Mann sold 162,153 shares of the firm's stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $5.75, for a total value of $932,379.75. Following the sale, the chairman directly owned 7,759,538 shares in the company, valued at approximately $44,617,343.50. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Heather Kiessling sold 80,000 shares of the business's stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total transaction of $464,000.00. Following the sale, the chief financial officer directly owned 732,500 shares in the company, valued at approximately $4,248,500. The trade was a 9.85% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 505,591 shares of company stock worth $3,233,245. Company insiders own 14.40% of the company's stock. Hedge Funds Weigh In On ASP IsotopesSeveral large investors have recently modified their holdings of ASPI. Exchange Traded Concepts LLC purchased a new stake in shares of ASP Isotopes in the 2nd quarter valued at about $9,593,000. AlphaQuest LLC bought a new position in shares of ASP Isotopes in the second quarter worth approximately $256,000. Rovida Advisors Inc. bought a new position in shares of ASP Isotopes in the second quarter worth approximately $16,148,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in ASP Isotopes in the second quarter valued at approximately $331,000. Finally, Harbour Capital Advisors LLC purchased a new stake in ASP Isotopes in the second quarter valued at approximately $232,000. Institutional investors own 16.80% of the company's stock. About ASP Isotopes (Get Free Report)ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.Featured StoriesFive stocks we like better than ASP IsotopesElon Taking SpaceX Public! $100 Pre-IPO Opportunity!How a Family Trust May Be Able To Help Preserve Your WealthA U.S. “birthright” claim worth trillions - activated quietlyExecutive Order 14330: Trump’s Biggest YetThe Crash Has Already Started (Most Just Don’t See It Yet)This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in ASP Isotopes Right Now?Before you consider ASP Isotopes, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.While ASP Isotopes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here